The MIF homologue d-dopachrome tautomerase promotes COX-2 expression through β-catenin-dependent and -independent mechanisms

Molecular Cancer Research

Volumn 8, Issue 12, 2010, Pages 1601-1609

  Xin, Dan ^b   Rendon, Beatriz E ^b   Zhao, Ming ^b   Winner, Millicent ^b   Coleman, Arlixer McGhee ^b   Mitchell, Robert A ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BINDING PROTEIN; CYCLOOXYGENASE 2; D DOPACHROME TAUTOMERASE; MACROPHAGE MIGRATION INHIBITION FACTOR; PROTEIN JAB1; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; COLORECTAL CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REGULATORY MECHANISM;

BETA CATENIN; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; HCT116 CELLS; HELA CELLS; HT29 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MAP KINASE KINASE 4; PEPTIDE HYDROLASES;

EID: 78650443177     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-10-0101     Document Type: Article

References (42)

1. Phelps RA, Chidester S, Dehghanizadeh S, et al.A two-step model for colon adenoma initiation and progression caused by APC loss. Cell 2009;137:623-34.
2. Quyn AJ, Steele RJ, Carey FA, Nathke IS. Prognostic and therapeutic implications of Apc mutations in colorectal cancer. Surgeon 2008;6:350-6.
3. Wong NA, Pignatelli M. Beta-catenin-a linchpin in colorectal carcinogenesis? Am J Pathol 2002;160:389-401.
4. Araki Y, Okamura S, Hussain SP, et al.Regulation of cyclooxygenase-2 expression by the Wnt and Ras pathways. Cancer Res 2003;63:728-34.
5. Zhao S, Cai J, Bian H, Gui L, Zhao F. Synergistic inhibition effect of tumor growth by using celecoxib in combination with oxaliplatin. Cancer Invest 2009;27:636-40.
6. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998;93:705-16.
7. Lev-Ari S, Strier L, Kazanov D, et al.Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Clin Cancer Res 2005;11:6738-44.
8. Adam L, Mazumdar A, Sharma T, Jones TR, Kumar R. A three-dimensional and temporo-spatial model to study invasiveness of cancer cells by heregulin and prostaglandin E2. Cancer Res 2001;61:81-7.
9. Chun KS, Surh YJ. Signal transduction pathways regulating cyclooxygenase-2 expression: Potential molecular targets for chemoprevention. Biochem Pharmacol 2004;68:1089-100.
10. Sheng H, Shao J, Kirkland SC, et al.Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 1997;99:2254-9.
11. Bertagnolli MM, Eagle CJ, Zauber AG, et al.Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial. Cancer Prev Res (Phila Pa) 2009;2:310-21.
12. Mitchell RA, Liao H, Chesney J, et al.Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: Regulatory role in the innate immune response. Proc Natl Acad Sci U S A 2002;99:345-50.
13. Sampey AV, Hall PH, Mitchell RA, Metz CN, Morand EF. Regulation of synoviocyte phospholipase A2 and cyclooxygenase 2 by macrophage migration inhibitory factor. Arthritis Rheum 2001;44:1273-80.
14. Carli C, Metz CN, Al-Abed Y, Naccache PH, Akoum A. Up-regulation of cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic cells by macrophage migration inhibitory factor: Involvement of novel kinase signaling pathways 2009 ; Endocrinology 2009;150:3128-37.
15. Itoh A, Nishihira J, Makita H, Miyamoto K, Yamaguchi E, Nishimura M. Effects of IL 1beta, TNF-alpha, and macrophage migration inhibitory factor on prostacyclin synthesis in rat pulmonary artery smooth muscle cells. Respirology 2003;8:467-72.
16. Rosengren E, Bucala R, Aman P, et al.The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction. Mol Med 1996;2:143-9.
17. Zhang M, Aman P, Grubb A, et al.Cloning and sequencing of a cDNA encoding rat Ddopachrome tautomerase. FEBS Lett 1995;373:203-6.
18. Sugimoto H, Taniguchi M, Nakagawa A, Tanaka I, Suzuki M, Nishihira J. Crystal structure of human D-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54 A resolution. Biochemistry 1999;38:3268-79.
19. Coleman AM, Rendon BE, Zhao M, et al.Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase. J Immunol 2008;181:2330-7.
20. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999;398:422-6.
21. Rendon BE, Roger T, Teneng I, et al.Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor. J Biol Chem 2007;282:29910-8.
22. Brattain MG, Fine WD, Khaled FM, Thompson J, Brattain DE. Heterogeneity of malignant cells from a human colonic carcinoma. Cancer Res 1981;41:1751-6.
23. Rendon BE, Willer SS, Zundel W, Mitchell RA. Mechanisms of macrophage migration inhibitory factor (MIF)-dependent tumor microenvironmental adaptation. Exp Mol Pathol 2009;86:180-5.
24. MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: Components, mechanisms, and diseases. Dev Cell 2009;17:9-26.
25. Zhang R, Chen HZ, Liu JJ, et al.SIRT1 suppresses activator protein-1 transcriptional activity and cyclooxygenase-2 expression in macrophages. J Biol Chem 2009;285:7097-110.
26. Lee KM, Lee KW, Bode AM, Lee HJ, Dong Z. Tpl2 is a key mediator of arseniteinduced signal transduction. Cancer Res 2009;69:8043-9.
27. Looby E, Abdel-Latif MM, thie-Morales V, Duggan S, Long A, Kelleher D. Deoxycholate induces COX-2 expression via Erk1/2-, p38-MAPK- and AP-1-dependent mechanisms in esophageal cancer cells. BMC Cancer 2009;9:190.
28. Kleemann R, Hausser A, Geiger G, et al.Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 2000;408:211-6.
29. Castellone MD, Teramoto H, Williams BO, Druey KM, Gutkind JS. Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science 2005;310:1504-10.
30. Goessling W, North TE, Loewer S, et al.Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell 2009;136:1136-47.
31. Lim K, Han C, Xu L, Isse K, Demetris AJ, Wu T. Cyclooxygenase-2-derived prostaglandin E2 activates beta-catenin in human cholangiocarcinoma cells: Evidence for inhibition of these signaling pathways by omega 3 polyunsaturated fatty acids. Cancer Res 2008;68:553-60.
32. Cuthbert RJ, Wilson JM, Scott N, Coletta PL, Hull MA. Differential CD74 (major histocompatibility complex class II invariant chain) expression in mouse and human intestinal adenomas. Eur J Cancer 2009;45:1654-63.
33. Oshima M, Dinchuk JE, Kargman SL, et al.Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996;87:803-9.
34. Sheng H, Shao J, Kirkland SC, et al.Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 1997;99:2254-9.
35. Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci U S A 1997;94:3336-40.
36. Dietrich WF, Lander ES, Smith JS, et al.Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 1993;75:631-9.
37. Chen D, Reierstad S, Lin Z, et al.Prostaglandin E(2) induces breast cancer related aromatase promoters via activation of p38 and c-Jun NH(2)-terminal kinase in adipose fibroblasts , Cancer Res 2007;67:8914-22.
38. Black SA Jr, Palamakumbura AH, Stan M, Trackman PC. Tissue-specific mechanisms for CCN2/CTGF persistence in fibrotic gingiva: Interactions between cAMP and MAPK signaling pathways, and prostaglandin E2-EP3 receptor mediated activation of the c-JUN N-terminal kinase. J Biol Chem 2007;282:15416-29.
39. Nateri AS, Spencer-Dene B, Behrens A. Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development. Nature 2005;437:281-5.
40. Sancho R, Nateri AS, de Vinuesa AG, et al.JNK signalling modulates intestinal homeostasis and tumourigenesis in mice. EMBO J 2009;28:1843-54.
41. Wilson JM, Coletta PL, Cuthbert RJ, et al.Macrophage migration inhibitory factor promotes intestinal tumorigenesis. Gastroenterology 2005;129:1485-503.
42. He XX, Chen K, Yang J, et al.Macrophage migration inhibitory factor promotes colorectal cancer. Mol Med 2009;15:1-10.